Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02254577 · ClinicalTrials.gov registry record · Phase 4
Vaginal Compared to Intramuscular Progesterone for Frozen Embryo Transfer
A Phase 4 study of Infertility, sponsored by Shady Grove Fertility Reproductive Science Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 1,139
- Enrollment target
- 14
- Study locations
NCT02254577: Completed Phase 4 study of Infertility, sponsored by Shady Grove Fertility Reproductive Science Center.
NCT02254577 is a Phase 4 study of Infertility that has completed, run by Shady Grove Fertility Reproductive Science Center. The registered enrollment target is 1,139 participants, below the 7,574-participant average among 74 other Infertility trials with a reported enrollment target (85% lower). The trial reports 14 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02254577, a Phase 4 study of Infertility, has completed, sponsored by Shady Grove Fertility Reproductive Science Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 1,139 participants
- Enrollment target
- 14
- Study locations
Study Summary
To determine whether the of vaginal progesterone replacement for frozen embryo transfer results in equivalent live birth rates to intramuscular injection progesterone replacement.
Primary Outcome
Live born infant at 23 weeks' estimated gestational age or greater.
Conditions Studied
Interventions
- DRUG Endometrin® plus Progesterone in Oil (PIO)
- DRUG Progesterone in Oil (PIO) Only
Study Locations (14)
Maryland
- Shady Grove Fertility Center - Annapolis
- Shady Grove Fertility Center - Baltimore
- Shady Grove Fertility Center - Bel Air
- Shady Grove Fertility Center - Columbia
- Shady Grove Fertility Center - Frederick
- Shady Grove Fertility Center - Rockville
- Shady Grove Fertility Center - Towson
Virginia
- Shady Grove Fertility Center - Annandale
- Shady Grove Fertility Center - Leesburg
- Shady Grove Fertility Center - Woodbridge
District of Columbia
- Shady Grove Fertility Center - Washington D.C.
- Shady Grove Fertility Center - Washington D.C.
Pennsylvania
- Shady Grove Fertility - Camp Hill
- Shady Grove Fertility Center - Chesterbrook
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,139 participants |
| Start Date | 2014-10 |
| Est. Completion | 2018-04-27 |
| Phase | Phase 4 |
What the finished NCT02254577 record still lists
NCT02254577 is an interventional study that assigns participants to a tested intervention. Its 1,139 participants enrollment target places it among the larger protocols in the corpus, below the 7,574-participant average among 74 other Infertility trials with a reported enrollment target (85% lower).
The record links to 1 condition, with Infertility appearing as the primary indexed condition, and to 2 interventions - of which Endometrin® plus Progesterone in Oil (PIO) is the first listed.
NCT02254577 lists 14 locations in 4 states (Maryland, Virginia, District of Columbia).
Frequently Asked Questions
What is clinical trial NCT02254577 about?
NCT02254577 is a clinical study titled "Vaginal Compared to Intramuscular Progesterone for Frozen Embryo Transfer". To determine whether the of vaginal progesterone replacement for frozen embryo transfer results in equivalent live birth rates to intramuscular injection progesterone replacement.
What is the current status of trial NCT02254577?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 1,139 participants. The study started on 2014-10. Estimated completion is 2018-04-27.
What conditions does trial NCT02254577 study?
This clinical trial studies the following conditions: Infertility.
What interventions are being tested in trial NCT02254577?
The interventions under investigation include: Endometrin® plus Progesterone in Oil (PIO) (DRUG), Progesterone in Oil (PIO) Only (DRUG).
Who is sponsoring clinical trial NCT02254577?
This trial is sponsored by Shady Grove Fertility Reproductive Science Center, which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02254577 being conducted?
This trial has 14 study locations across District of Columbia, Maryland, Pennsylvania, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Infertility
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02254577's enrollment target sits among peer trials
1,139 17th of 74 higher than 58 of 74 other Infertility trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Infertility trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
GnRH for Luteal Support in IVF/ICSI/FET Cycles
RECRUITING · Phase 4
-
Randomized Controlled Trial of Combined Letrozole and Clomid (CLC II) Versus Letrozole Alone for Women With Anovulation
ACTIVE NOT RECRUITING · Phase 4
-
Endometrial Markers and Response of Endometriosis Patients to Prolonged GnRH Agonist Prior to IVF
COMPLETED · Phase 4
-
Concomitant Administration of FSH With HCG Improves Oocyte Maturation and Quality Double -Blinded Randomized Trial
COMPLETED · Phase 4
-
Menopur Mixed Protocol
COMPLETED · Phase 4
-
Gamete Treatment to Correct Fertilization Failure
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05894967 · 1,140 participants · NA
Moderators and Mediators of Perceptual Learning
- NCT06532487 · 1,140 participants · NA
Addressing Durable Health Disparities Through Critical Time Legal Interventions in Medically Underserved Latinx and Migrant Communities
- NCT06129864 · 1,145 participants · Phase 3
A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy
- NCT06676319 · 1,147 participants · Phase 2
Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia